The 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)

The 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020) is organized by Kenes Group, TWT srl and will be held from Feb 19 - 22, 2020 at IFEMA Municipal Palace, Madrid, Spain.

Target Audience:
ATTD 2020 is the global meeting place for physicians, researchers, scientists in the field of endocrinology, pediatrics, family medicine. Because of the diverse, clinically focused educational offering, participants are able to tailor the curriculum to meet the needs of international clinicians of all levels of experience.

Credit Designation:
The 13th International Conference on Advanced Technologies & Treatments for Diabetes is designated for a maximum of, or up to, 12 European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Description:
Mark your calendar for the ultimate meeting place for clinical practitioners, industry and corporate professionals, researchers, nurses, entrepreneurs, scientists, and decision-makers from around the globe, to discuss the latest technological advancements, developments, opportunities and challenges in the treatment of diabetes.

Over the past decade, remarkable changes occurred in the development and the use of new technologies for treating patients with diabetes and the annual ATTD meetings have become the premier international forum to present and discuss these innovations.

ATTD initiative, where clinicians, diabetes care providers, researchers, industries, start-ups, investors and reimbursement authorities convene at ATTD annual meetings with the aim to promote, support and enhance the development of novel technologies and treatments for diabetes.

Presentations and discussions will be given by many distinguished professionals in the field and will include topics such as decision support systems/Advisors, glucose sensors, closed-and open-loop systems, artificial pancreas, devices for diabetic prevention, new insulins and new medications, insulin pumps and many more.

Educational Objectives:
After attending this event, participants should be able to:
• Address individual needs in compliance with their Continuous Professional Development (CPD) plan.
• Exchange ideas and knowledge about novel biomarkers for diabetes.
• Review the latest artificial pancreas (AP) developments.
• Discuss insulin pump treatment and insulin sensitivity during pregnancy
• Discuss the impact of hypoglycemia on patient-reported outcomes.
• Discuss an update on therapies in Type 1 Diabetes.
• Discuss the continuous glucose monitoring (CGM) as initial diabetes technology.
• Review new technologies for treating obesity and preventing related diabetes.